70 likes | 424 Views
Indigenous PCV 15 - An a ffordable , Asia specific Pneumococcal Conjugate Vaccine – Current status of development. M. Kuppusamy , Ph.D Managing Director, Tergene Biotech Pvt. Ltd., Hyderabad. PCV - 15. Pneumococcal Conjugate Vaccine Design. Serotypes included:
E N D
Indigenous PCV 15 - An affordable, Asia specific Pneumococcal Conjugate Vaccine – Current status of development M. Kuppusamy, Ph.D Managing Director, Tergene Biotech Pvt. Ltd., Hyderabad
PCV - 15 Pneumococcal Conjugate Vaccine Design Serotypes included: 15 types of pneumococcal polysaccharides 1, 2, 3, 4, 5, 6A, 6B, 7F, 9V, 12F, 14, 18C, 19A, 19F, 23F Source of Strains: CDC, Atlanta Carrier protein: CRM 197 Diphtheria Toxin (Non-recombinant) Conjugation Chemistry: Cyanalation, Adipic acid linker, Carbo-di-imide cross linking
PCV - 15 Vaccine Formulations
PCV - 15 Region wise Serotype Coverage * Pneumococcal Regional Serotype Distribution for Pneumococcal AMC TPP, 2008
PCV - 15 Current Status of PCV - 15 • In House technology development & Proof of concept established in 2010 • Production of GMP lots for pre-clinical and clinical studies under progress • Commercial launch expected in 4th quarter of 2014 • Project supported by DBT, Govt. of India
PCV - 15 THANK YOU!